Sebastijan Hobor
The Francis Crick Institute(GB)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, RNA modifications and cancer, Radiomics and Machine Learning in Medical Imaging
Most-Cited Works
- → Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer(2012)1,867 cited
- → Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients(2015)1,079 cited
- → Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma(2014)899 cited
- → Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer(2013)658 cited
- → Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal(2018)650 cited
- → Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3(2014)310 cited
- → Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer(2014)268 cited
- → Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer(2015)268 cited
- → Erratum: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients(2015)259 cited
- → KRAS gene amplification in colorectal cancer and impact on response to EGFR‐targeted therapy(2013)177 cited